XML 46 R30.htm IDEA: XBRL DOCUMENT v3.6.0.2
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2016
Stockholders' Equity Note [Abstract]  
Fair Value Valuation Assumptions
The estimated fair value of the Company’s PBO was determined using a Monte Carlo model, which incorporated the following assumptions:
 
2015
10-Year Option
 
2014
10-Year Option
 
2014
4.58-Year Option
Grant date
8/12/2015

 
11/14/2014

 
11/14/2014

Expiration date
8/12/2025

 
11/14/2024

 
6/14/2019

Grant date stock price
$
13.06

 
$
19.51

 
$
19.51

Historical volatility
35.16
%
 
35.00
%
 
28.85
%
Risk-free rate (annualized)
2.19
%
 
2.38
%
 
1.5
%
Dividend yield (annualized)
%
 
%
 
%
PBO granted
75,000

 
167,619

 
285,714

Weighted average grant date fair value
$
5.87

 
$
6.51

 
$
6.51

Fair value of award on grant date
$
440,000

 
$
1,475,705

 
$
1,474,672


Summary of ISO Activity
A summary of PBO activity was as follows:
 
Performance-Based Options
 
Weighted-Average Exercise Price Per Share
Outstanding at December 31, 2014
453,333

 
$
19.51

Granted
75,000

 
$
13.06

Forfeited
(75,000
)
 
$
13.06

Outstanding at December 31, 2015 and 2016
453,333

 
$
19.51


Of the PBO outstanding at December 31, 2016, 285,714 expired and were canceled on January 8, 2017 in conjunction with the termination of the Company’s former CEO. The remaining 167,619 PBO outstanding are exercisable for up to 10 years from the grant date.

 
Performance-Based Options
 
Weighted-Average Exercise Price Per Share
 
Weighted-Average Contractual Term Remaining (Years)
 
Aggregate Intrinsic Value
Vested at December 31, 2014
12,593

 
 
 
 
 
 
Vested
155,278

 
 
 
 
 
 
Forfeited
(4,167
)
 
 
 
 
 
 
Vested at December 31, 2015
163,704

 
$
19.51

 
5.5
 

Vested
238,413

 
 
 
 
 
 
Vested at December 31, 2016
402,117

 
$
19.51

 
4.5
 

Summary of RSU and RSA Activity
A summary of RSU activity was as follows:
 
RSU Shares
 
Weighted-Average Grant Date Fair Value Per Share
Outstanding and unvested at December 31, 2013
469,435

 
$
30.43

Granted
142,131

 
$
19.81

Vested
(469,435
)
 
$
30.43

Outstanding and unvested at December 31, 2014
142,131

 
$
19.81

Granted
23,300

 
$
15.68

Vested
(45,753
)
 
$
20.43

Forfeited
(11,020
)
 
$
15.72

Outstanding and unvested at December 31, 2015
108,658

 
$
19.07

Granted
24,326

 
$
10.28

Vested
(76,152
)
 
$
19.14

Forfeited
(8,600
)
 
$
17.30

Outstanding and unvested at December 31, 2016
48,232

 
$
14.85

Schedule of Share-based Compensation, Stock Appreciation Rights Award Activity
A summary of SAR activity is as follows:
 
SAR Shares
 
Weighted Average Exercise Price Per Share
 
Weighted Average Contractual Term Remaining (Years)
Outstanding and exercisable at December 31, 2013
1,616,625

 
$
36.45

 
2.5
Expired
(20,000
)
 
$
33.76

 
 
Outstanding and exercisable at December 31, 2014
1,596,625

 
$
36.49

 
1.5
Expired
(1,110,155
)
 
$
33.76

 
 
Outstanding and exercisable at December 31, 2015
486,470

 
$
42.71

 
1.5
Expired
(20,000
)
 
$
42.71

 
 
Outstanding and exercisable at December 31, 2016
466,470

 
$
42.71

 
0.6